Note: Ingredients listed on restricted chemical lists
EC/CAS
141-78-6
Name of the chemical
acetic acid, ethyl ester
Concentration
N/A
EC/CAS
123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
N/A
EC/CAS
9004-36-8
Name of the chemical
cellulose acetate butyrate
Concentration
N/A
EC/CAS
6846-50-0
Name of the chemical
2,2,4-trimethyl-1,3-pentanediol diisobutyrate
Concentration
N/A
EC/CAS
5232-99-5
Name of the chemical
2-cyano-3,3-diphenylacrylic acid, ethyl ester
Concentration
N/A
EC/CAS
131-56-6
Name of the chemical
2,4-Dihydroxybenzophenone
Concentration
N/A
EC/CAS
81-48-1
Name of the chemical
2,2′-[Cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-cyclohexylphenol] (Solvent Yellow 29; CI 21230) when used as a substance in hair dye products
Concentration
N/A
EC/CAS
205-029-4
Name of the chemical
2,4-Dihydroxybenzophenon; Resbenzophenone
Concentration
N/A
EC/CAS
201-353-5
Name of the chemical
2,2′-[Cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-cyclohexylphenol] (Solvent Yellow 29; CI 21230) when used as a substance in hair dye products
Concentration
N/A
General Information
Revision date
2008-01-10
Product name
NTT30
Chemical name
SOLVENT MIXTURE
Manufacturer Name
OPI PRODUCTS, INC
Icons in SDS
Company Information
company name
OPI PRODUCTS, INC
Section 2
SECTION 2: Hazards identification
Flammable liquid. This product is classified as a HAZARDOUS SUBSTANCE and as DANGEROUS GOODS according to the classification criteria of [NOHSC:1088(1999)] and ADG Code (Australia). Routes of Entry: Inhalation: YES Absorption: YES Ingestion: YES Effects of Exposure: INGESTION: If product is swallowed, may cause nausea, vomiting and/or diarrhea and central nervous system depression. SKIN & EYES: Irritating to the eyes. Symptoms of overexposure may include redness, itching, irritation and watering. May be irritating to skin in some sensitive individuals, especially after prolonged and/or repeated contact. INHALATION: Vapors of this product may be slightly irritating to the nose, throat and other tissues of the respiratory system. Symptoms of overexposure can include coughing, wheezing, nasal congestion, and difficulty breathing. Inhalation of vapors exceeding the levels listed in Section 2 (Composition and Ingredient Information) can cause central nervous system depression (e.g., drowsiness, dizziness, headaches, nausea). 2.4 Symptoms of Overexposure: Symptoms of skin overexposure in individuals may include redness, itching, and irritation of affected areas. Overexposure in eyes may cause redness, itching and watering. 2.5
Potential Acute Health Effects
Mild to moderate irritation to eyes and skin near affected areas. Additionally, high concentrations of vapors can cause drowsiness, dizziness, headaches and nausea. 2.6
Potential chronic health
None known. 2.7 Target Organs: Eyes, skin and respiratory system. NA = Not Available; ND = Not Determined; NE = Not Established; C = Ceiling Limit; See Section 16 for Additional Definitions of Terms Used NOTE: all WHMIS required information is included. It is located in appropriate sections based on the ANSI Z400.1-2004 format.
